Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,469 | 254 | 99.9% |
| Education | $5.40 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $914.99 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $809.38 | 49 | $0 (2024) |
| Amgen Inc. | $496.76 | 27 | $0 (2024) |
| Novo Nordisk Inc | $370.86 | 21 | $0 (2024) |
| PFIZER INC. | $288.15 | 16 | $0 (2024) |
| ABBVIE INC. | $183.69 | 9 | $0 (2024) |
| Abbott Laboratories | $136.27 | 7 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $126.66 | 7 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $118.97 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $115.95 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.48 | 43 | AstraZeneca Pharmaceuticals LP ($173.19) |
| 2023 | $625.06 | 34 | Lilly USA, LLC ($186.39) |
| 2022 | $249.95 | 14 | AstraZeneca Pharmaceuticals LP ($85.49) |
| 2021 | $683.73 | 37 | Lilly USA, LLC ($147.71) |
| 2020 | $830.74 | 50 | AstraZeneca Pharmaceuticals LP ($182.75) |
| 2019 | $545.02 | 35 | AstraZeneca Pharmaceuticals LP ($141.21) |
| 2018 | $311.19 | 23 | AstraZeneca Pharmaceuticals LP ($123.26) |
| 2017 | $375.98 | 19 | Lilly USA, LLC ($173.96) |
All Payment Transactions
255 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Diabetes Care | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Insomnia | ||||||
| 09/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Inflammation | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: WOMENS HEALTH | ||||||
| 08/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: NEUROLOGY | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Inflammation | ||||||
| 08/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Oncology | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Cardio-renal | ||||||
| 05/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Gastroenterology | ||||||
| 05/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,733 | 2,862 | $498,872 | $188,334 |
| 2022 | 20 | 1,673 | 2,619 | $459,221 | $171,868 |
| 2021 | 20 | 1,859 | 2,746 | $508,571 | $194,051 |
| 2020 | 19 | 1,736 | 2,584 | $390,550 | $146,051 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 298 | 1,027 | $257,777 | $86,469 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 216 | 216 | $55,296 | $25,539 | 46.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 48 | 358 | $44,750 | $16,478 | 36.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 186 | 187 | $31,229 | $14,245 | 45.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 190 | $34,010 | $11,432 | 33.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 99 | 99 | $12,672 | $7,118 | 56.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 24 | 25 | $13,575 | $5,119 | 37.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 237 | 237 | $8,769 | $4,195 | 47.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 220 | 220 | $7,920 | $3,894 | 49.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $11,254 | $3,212 | 28.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 21 | $8,463 | $3,119 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 102 | 102 | $3,570 | $3,084 | 86.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 14 | 14 | $4,606 | $2,230 | 48.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 70 | 71 | $3,763 | $1,796 | 47.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $493.00 | $180.48 | 36.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 15 | 15 | $435.00 | $124.08 | 28.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 29 | $290.00 | $98.89 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 298 | 965 | $242,575 | $81,334 | 33.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 198 | 198 | $50,623 | $24,585 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 221 | $39,607 | $13,196 | 33.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 169 | 169 | $28,168 | $10,810 | 38.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 36 | 216 | $27,000 | $10,360 | 38.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 86 | 87 | $11,130 | $5,960 | 53.5% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 225 | 225 | $8,325 | $4,086 | 49.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 17 | 17 | $9,241 | $3,626 | 39.2% |
About Dr. Fabio Echavarria, M.D
Dr. Fabio Echavarria, M.D is a Internal Medicine healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710984687.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fabio Echavarria, M.D has received a total of $4,474 in payments from pharmaceutical and medical device companies, with $852.48 received in 2024. These payments were reported across 255 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($4,469).
As a Medicare-enrolled provider, Echavarria has provided services to 7,001 Medicare beneficiaries, totaling 10,811 services with total Medicare billing of $700,305. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Clermont, FL
- Active Since 07/06/2005
- Last Updated 01/23/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710984687
Products in Payments
- FARXIGA (Drug) $501.19
- JARDIANCE (Drug) $309.46
- Otezla (Drug) $267.00
- EMGALITY (Drug) $243.55
- Ozempic (Drug) $236.36
- MOUNJARO (Drug) $212.41
- Livalo (Drug) $126.66
- FORTEO (Drug) $113.08
- BYDUREON (Drug) $111.70
- Aimovig (Biological) $108.87
- Kerendia (Drug) $97.09
- QULIPTA (Drug) $92.72
- AIRSUPRA (Drug) $91.25
- UBRELVY (Drug) $86.61
- EVENITY (Biological) $82.59
- FREESTYLE LIBRE 2 (Device) $78.74
- INVOKANA (Drug) $78.55
- NEXLETOL (Drug) $75.70
- SHINGRIX (Biological) $75.20
- CHANTIX (Drug) $64.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clermont
Sumith Aleti, Md, MD
Internal Medicine — Payments: $29,143
Alexander Bolanos, M.d, M.D
Internal Medicine — Payments: $15,769
Nathan Bibliowicz, Do, DO
Internal Medicine — Payments: $14,320
Dr. Shazia Nasir, Md, MD
Internal Medicine — Payments: $11,207
Carolina Mejia Otero, M.d, M.D
Internal Medicine — Payments: $7,926
Dr. Kiran Mogali, M.d, M.D
Internal Medicine — Payments: $7,620